Article
Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.
Antimicrobial agents and chemotherapy - 1 Dec 2010
Baughn Anthony D, Deng Jiaoyu, Vilchèze Catherine, Riestra Angelica, Welch John T, Jacobs William R, Zimhony Oren
Abstract excerpt
The pyrazinamide (PZA) analog 5-chloropyrazinamide (5-Cl PZA) is active against mycobacterial species, including PZA-resistant strains of Mycobacterium tuberculosis. In M. smegmatis, overexpression of the type 1 fatty acid synthase (FAS I) confers resistance to 5-Cl PZA, a potent FAS I inhibitor. Since M. tuberculosis and M. bovis cannot tolerate FAS I overexpression, 5-Cl PZA resistance mutations have yet to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
